Neuralink Blindsight receives FDA Breakthrough Device Designation for visually impaired patients
Neuralink’s work on brain-interface technology includes a project called Blindsight, designed to restore sight to people who have lost or never had it through innovative medical implant tech. This Blindsight segment of Neuralink has been recognized by the FDA as a Breakthrough Device, signifying significant progress in this field.